期刊文献+

透明质酸修饰载紫杉醇靶向脂质体抑制脑肿瘤干细胞的初步评价 被引量:8

Primary evaluation on inhibiting effects of hyaluronic acid modified paclitaxel loaded liposome against brain tumor stem cells
原文传递
导出
摘要 目的:制备透明质酸修饰载紫杉醇(paclitaxel,PTX)靶向脂质体(HALP-PTX),考察其对脑胶质瘤肿瘤干细胞的亲和力和抑制效果。方法:采用薄膜分散法制备HALP-PTX,细胞摄取实验研究胶质瘤干细胞对脂质体的摄取。MTT实验研究不同紫杉醇药物对肿瘤干细胞的增殖抑制率。构建原位移植瘤动物模型,考查不同脂质体对荷瘤裸鼠的生存期的影响。结果:肿瘤干细胞对HALP的摄取能力显著大于普通脂质体(LP),脑肿瘤干细胞对经透明质酸修饰的脂质体的摄取效率是普通脂质体的2.8倍,差异有统计学意义(P<0.01);HALP-PTX对肿瘤干细胞的生长的抑制作用显著强于LP-PTX,HALPPTX能够显著延长荷瘤裸鼠的中位生存期,生理盐水组、PTX组、LP-PTX组和HALP-PTX组的中位生存期分别为19,23,29,41 d。结论:与PTX以及LP-PTX相比,HALP-PTX能够更加有效的被脑肿瘤干细胞识别和摄取,抑制肿瘤细胞的增殖,具有更强的抗肿瘤作用。 OBJECTIVE To prepare hyaluronic acid conjugated paclitaxel loaded liposome and evaluate the efficiency of cellular uptake and the inhibiting effects against brain cancer stem cells. METHODS Liposome was prepared by film-ultrasonic method. Cellular uptake by brain tumor stem cell was explored. The anti-proliferation efficiency of HALP-PTX was evaluated by MTT assay. Brain tumor stem cells were used to build orthotopic tumor model, which was used to evaluate the anti-cancer effects. RESULTS The uptake efficiency of HALP was 2. 8 times higher than that of LP (P〈0. 01). The anti-proliferative activity against brain tumor stem cell confirmed strong inhibitory effects of HALP-PTX. HALP-PTX could significantly prolong median survival of nude rats. The median survival of nude rats in saline, PTX, LP-PTX and HALP-PTX groups were 19, 23, 29 d and 41 d. CONCLUSION Comparing with PTX and LP-PTX, HALP-PTX can more persistently inhibit the proliferation of brain tumor stem cells. Therefore, as a new nanometer drug, HALP-PTX has a special applying value for therapy of brain tumor.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第9期773-776,共4页 Chinese Journal of Hospital Pharmacy
基金 国家自然基金项目(编号:81472335)
关键词 透明质酸 紫杉醇 脂质体 肿瘤干细胞 hyaluronic acid paclitaxel liposome tumor stem cell
  • 相关文献

参考文献15

  • 1Chen H, Tang L, Qin Y, et al. Lactoferrin-modified proca- tionic liposomes as a novel drug carrier for brain delivery[J]. Eur J Pharm Sci,2010,40(2) ; 10 18.
  • 2A1 Soraj M, He L, Peynshaert K, et al. siRNA and pharma cological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating pep- tides octaarginine (RS) and HIV Tat[J]. J Control Release, 2012,161(1) : 132-141.
  • 3Mannelli G, Gallo O. Cancer stem cells hypothesis and stem ceils in head and neck cancers[J]. Cancer Treat Rev, 2012, 38 (5) : 515-539.
  • 4Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhib- its prostate cancer stem cells and metastasis by directly re- pressing CD44[J]. Nat Med,2011, 17(2): 211-215.
  • 5QianyuZhang. A pH responsive a-helical cell penetrating pep tide-mediated liposomal delivery system [J]. Biomaterials, 2013,34 (32) : 7980-7993.
  • 6Su J, Xu XH, Huang Q, et al. Identification of Cancer Stern like CD44 + Cells in Human Nasopharyngeal Carcinoma Cell Line [J]. Arch Med Res,2011,42(1) :15-21.
  • 7李建林,孟路华,赵玉玺,潘黎军,王驰.透明质酸磷脂酰衍生物修饰姜黄素脂质体的制备及细胞毒性[J].中国医药工业杂志,2013,44(5):471-474. 被引量:8
  • 8Qin Y, Chen H, Zhang Q, et al. Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals [J]. Int J Pharm,2011, 420(2) : 304-312.
  • 9Huile G1, Shuaiqi P, Zhi Y, etal. A cascade targeting strate- gy for brain neuroglial cells employing nanoparticles modifiedwith angiopep-2 peptide and EGFP-EGF1 protein [J]. Bioma- terials,2011,32(33) : 8669 8675.
  • 10Chang S, Guo J, Sun J, et al. Targeted microbubbles for ul- trasound mediated gene transfection and apoptosis induction in ovarian cancer cells[J]. Ultrasonics Sonochemistry, 2013,20 (1) : 171-179.

二级参考文献11

  • 1许东晖,王胜,金晶,梅雪婷,许实波.姜黄素的药理作用研究进展[J].中草药,2005,36(11):1737-1740. 被引量:88
  • 2Park K, Lee MY, Kim KS, et al. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate [J]. Biomaterials, 2010, 31 (19) : 5258-5265.
  • 3Naor D, Wallach-Dayan SB, Zahalka MA, et al. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination [J]. Semin Cancer Biol, 2008, 18 (4): 260-267.
  • 4Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours [J]. Eur J Cancer, 2010, 46 (7) : 1271-1277.
  • 5Surace C, Arpicco S, Dufa:-Wojcicki A, et al. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells [J]. Mol Pharm, 2009, 6(4): 1062-1073.
  • 6Eliaz RE, Szoka FC Jr. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells EJ]. CancerRes, 2001, 61 (6) : 2592-2601.
  • 7Taetz S, Bochot A, Surace C, et al. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti- telomerase siRNA to CD44-expressing lung cancer cells [J]. Oligonucleotides, 2009, 19 (2): 103-116.
  • 8Oh EJ, Park K, Kim KS, et al. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic :d derivatives [J]. J Controlled Release, 2010, 141 (1) : 2-12.
  • 9Wojcicki AD, Hillaireau H, Nascimento TL, et al. Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptor [J]. J Controlled Release, 2012, 162 (3) : 545-552.
  • 10李彧,杨丽霞,李亚东,刘铜华,王继峰.姜黄素抗纤维化作用研究进展[J].北京中医药大学学报,2008,31(6):408-411. 被引量:12

共引文献7

同被引文献101

  • 1赵静,刘艳,解军波,王凤玲,张彦青.中药纳米递药系统的研究进展[J].中华中医药学刊,2022,40(5):134-137. 被引量:7
  • 2黄吉春,蔡华荣,江跃全.双功能RGD-TAT肽修饰脂质体的构建及其脑胶质瘤靶向性研究[J].中国生化药物杂志,2014,34(3):1-3. 被引量:5
  • 3薛小平,赵连根.血-脑屏障研究进展[J].微循环学杂志,2006,16(3):64-68. 被引量:5
  • 4Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 [J]. Neuro Oncol, 2015, 17 Suppl 4: ivl-iv62, doi: 10,1093/neuonc/nov189.
  • 5Ellis HP, Greenslade M, Powell B, et al. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Dis- ease, and Models to Predict Disease Recurrence [J]. Front Oncol, 2015, 5: 251. doi: 10.3389/fonc,2015.00251.
  • 6Lima FR, Kahn SA, Soletti RC, et al. Glioblastoma: therapeutic challenges, what lies ahead [J]. Biochim Biophys Acta, 2012, 1826(2): 338-349. doi: 10,1016/ j.bbcan,2012.05.004.
  • 7Champ CE, Siglin J, Mishra MV, et al. Evaluating changes in radiation treatment volumes from post-operative to same- day planning MRI in High-grade gliomas [J]. Radiat Oncol, 2012, 7: 220. doi: 10,1186/1748-717X-7-220.
  • 8Chen S, Tanaka S, Giannini C, et al. Gliomatosis cerebri: clinical characteristics, management, and outcomes [J]. J Neurooncol, 2013, 112(2): 267-275. doi: 10,1007/sl 1060- 013-1058-x.
  • 9Zhan C, Li B, Hu L, et al. Micelle-based brain-targeted drug delivery enabled by a nicotine acetylcholine recep- tor ligand [J]. Angew Chem Int Ed Engl, 2011, 50(24): 5482-5485. doi: 10,1002/anie,201100875.
  • 10Lu W, Wan J, She Z, et al. Brain delivery property and ac- celerated blood clearance of cationic albumin conjugated pegylated nanoparticle [J]. J Control Release, 2007, 118(1): 38-53.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部